Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Merck
Argus Health
US Department of Justice
Johnson and Johnson
Cantor Fitzgerald

Generated: April 25, 2019

DrugPatentWatch Database Preview

VI-TWEL Drug Profile

« Back to Dashboard

When do Vi-twel patents expire, and what generic alternatives are available?

Vi-twel is a drug marketed by Bayer Hlthcare and is included in one NDA.

The generic ingredient in VI-TWEL is cyanocobalamin. There are nine drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the cyanocobalamin profile page.

Summary for VI-TWEL
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 23
Formulation / Manufacturing:see details
DailyMed Link:VI-TWEL at DailyMed
Drug patent expirations by year for VI-TWEL
Synonyms for VI-TWEL
0.1% Cobalamin Concentrate Trituration w/Mannitol
1H-Benzimidazole,6-dimethyl-1-(3-O-phosphono-.alpha.-D-ribofuranosyl)-, monoester with cobinamide cyanide hydroxide, inner salt
5,6-Dimethylbenzimidazolyl cyanocobamide
5,6-Dimethylbenzimidazolyl-CO-cyanocobamide
68-19-9
AB2000361
AKOS015894306
alpha-(5,6-Dimethylbenzimidazolyl)cyanocobamide
Anacobin
B-Twelve
B-Twelve ora
Bedoz
BEROCCA PN
Berubigen
Betalin 12, crystalline
Betaline-12
Betolvex
Bevidox concentrate
Biocobalamine
Byladoce
C63H88CoN14O14P
Cabadon M
CAS-68-19-9
CCG-220433
Cobadoce forte
cobalamin
Cobalamin;vitamin B-12;Cyanocobalamin
Cobamide,6-dimethyl-1H-benzimidazole-
Cobamide,6-dimethyl-1H-benzimidazolyl-, cyanide
Cobavite
Cobinamide, dihydrogen phosphate
Cobinamide, dihydrogen phosphate (ester), inner salt, 3'-ester with 5,6-dimethyl-1-.alpha.-D-ribofuranosylbenzimidazole
Cobinamide,6-dimethyl-1-.alpha.-D-ribofuranosylbenzimidazole, inner salt
Cobinamide,dihydrogenphosphate(ester),inner salt,3'-ester with(5,6-Dimethyl-1-a-d-ribofuranosyl-1H-benzimidazole-kn3),ion(1+)(9ci)
Cobolin-M
component of Endoglobin
component of Vitron-C-Plus
Copharvit 5000
Covit
Crystamine
Crysti-12
Crystimin
Crystwel
Cyano-B12
Cyanobalamin concentrate
Cyanocob(III)alamin
cyanocobalamin
CYANOCOBALAMIN 0.1% IN MANNITOL
Cyanocobalamin;Cyanocob(III)alamin
Cyanocobalamine
cyanoject
Cycobemin
Cycolamin
Cykobemin
Cykobeminet
Cyomin
Cyredin
Cytacon
Cytamen
Cytobion
Depinar
Dicopac
Dimethylbenzimidazoylcobamide
Dobetin
Docemine
Docibin
Dodecabee
Dodecavite
Dodex
DSSTox_CID_24346
DSSTox_GSID_44346
DSSTox_RID_80159
DTXSID7044346
Ducobee
Duodecibin
Embiol
Emociclina
Eritrone
Erycytol
Erythrotin
Euhaemon
Extrinsic factor
Fresmin
H486
Hemomin
Hepagon
Hepcovite
HMS1569G08
HMS2096G08
HMS3713G08
Hylugel plus
Macrabin
Megalovel
Milbedoce
MolPort-016-633-264
Nagravon
Nascobal
NCGC00016302-01
NCGC00249888-01
Neuroforte-R
Normocytin
Novidroxin
NSC-80365
NSC80365
Pernaemon
Pernaevit
Pernipuron
Plecyamin
Poyamin
Prestwick_564
Primabalt
Rebramin
Redamina
Redisol
Rhodacryst
Rubesol
RUBIVITE
Rubramin PC
RUBRATOPE-60 KIT
Rubripca
Rubrocitol
RUVITE
Shovite
SRI 2215
Sytobex
Tox21_110358
Tox21_113664
V0344
Vibal
Vibalt
Vibisone
Virubra
Vita-rubra
Vitabee 12
vitamin B12
Vitamin B12 complex
Vitamin B12 preparation
Vitamin B12b
Vitamine B12
Vitarubin
Vitral
WLN: D C5656 B-5 B6 B5 S5 J&5 B-19- Q&6 N&5/B-N/DU/J&-M& J&- O& 9ABBBBCSTT V& AN-CO-&& B-N CN TN C&

US Patents and Regulatory Information for VI-TWEL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Hlthcare VI-TWEL cyanocobalamin INJECTABLE;INJECTION 007012-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Express Scripts
Cipla
Julphar
Daiichi Sankyo
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.